As who / what expected? There has been nothing new to indicate that this stock should be trading lower. If it trades much lower it will be trading below cash which is just crazy. If you are looking for a bargain stock with great risk / reward potential; this stock is it! Buy before ESMO.
Sentiment: Strong Buy
I wouldn't recommend getting into a short position this close to ESMO when they will update on the TARGET 2b NSCLC data. Recall that TARGET trial already met PFS in March, and OS was trending positive, with all data expected around the end of this year. Common sense tells me that if progression was reduced; then overall survival should also be improved. Also, they aren't preparing for this presentation the night before; didn't anyone notice the almost instant increase in activity on Aug. 28th? Volume has been at or above average ever since that date with nothing new announced. From the volume you can almost see the time information may have been leaked. I have an equal chance of being just as wrong as the next guy; but common sense tells me everything you are pumping into this message board is wrong; especially since you have not answered one question or made a bit of sense with any comment.
Sentiment: Strong Buy
No one can really know what range it will trade in. I'm expecting it to get to 7.75/8 right before ESMO then some profit taking will occur by those that don't think good news is coming. If good news does come out at ESMO I'd say a nice pop to between 10 and 11 depending on how good the news is.
A typical pump by those who were worried seeing stock in Death spiral and this is a typical try for one day only.....short and prosper...Guaranteed.
This is some RARE, Good + Honest advice. Thou Mccraiglist100 l am PRAYING the market sells off for at least a day or two beginning of the week to take some FROTH out and let me pick up ECYT for like 6.25 as short-sellers have the leverage to push it WELL below it's "fair value"
this is personally one of the most ignorant comments I have ever read. It is honestly the single worst comment I have ever read on this board for a company with 220 million and over 5$ in CASH per share. This stock is a steal when it drops under 6.50
You keep making negative comments on this stock. You must be short or you wouldn't waste your time.
well overpriced .. 5.50 in cash at end of the year so stock is worth 1.10 without cash. How much
overvalued is that ? You think the company is worth between 0 and under $1. What a loser.
If you think the runup before September 3rd was good, just wait until September 26-30. This will trade higher. If you want a quick buck then buy now and sell before ESMO. If you think ECYT is going to present good news then hold through ESMO.
Good stocks went up and bad ones were down. Increasing doubt in the company prospect coming out lately was long overdue. We expect more downward pressure in coming weeks as results come to play more bearish outlook .
buying scale down 6.40 to 6.05 and kicking out 7.05 to 7.25. continue to trade the range while waiting for some positive news if/when.
reading about immunotherapy being the future vs. small molecule drugs. pretty funny given the cost difference. either way, it is long from over for ecyt.